Skip to main content

Baader Bank Aktiengesellschaft

Bank

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1542629 Unterschleissheim, 2M

Position in REGN

as of Jun 30, 2026 · filed Jul 23, 2026
Position Value
$927,827
-$4,334,624 QoQ
Shares Held
1,488
-78.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#657
of 1,319 holders
Holding Since
Dec 2021
18 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Derivatives in REGN

reported options exposure · as of Jun 30, 2025
CallValue
$0
CallShares
0
PutValue
$2,835,000
PutShares
5,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Baader Bank Aktiengesellschaft holds $22,123,898 across 12 Biotechnology names. REGN ranks #3 (4.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 REGN
Regeneron Pharmaceuticals, Inc.
This page
1,488 $927,827

All Filings in REGN

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $927,827 1,488
2026-03-31 $5,262,451 6,811
2025-12-31 $2,202,145 2,853
2025-09-30 $1,440,535 2,562
2025-06-30 $7,501,725 14,289
2025-06-30 $2,835,000 5,400
2024-12-31 $616,877 866
2024-09-30 $993,421 945
2024-06-30 $1,016,346 967
2024-03-31 $678,555 705
2023-12-31 $649,934 740
2023-09-30 $624,626 759
2023-06-30 $524,534 730
2023-03-31 $681,164 829
2022-12-31 $584,406 810
2022-09-30 $557,984 810
2022-06-30 $620,686 1,050
2022-03-31 $893,977 1,280
2021-12-31 $808,345 1,280